UK woman receives experimental CAR T therapy for multiple sclerosis

A UK woman is the first patient to receive an experimental CAR T therapy for multiple sclerosis, potentially halting disease progression. The treatment involves genetically modifying the patient's own T cells to target and eliminate rogue immune cells responsible for MS damage. Doctors hope this single infusion could reset the immune system. This CAR T therapy, already used for blood cancers, is being tested in a global trial at University College London Hospitals, with early results showing promise for autoimmune diseases.